Aniracetam, 1-BCP and cyclothiazide differentially modulate the function of NMDA and AMPA receptors mediating enhancement of noradrenaline release in rat hippocampal slices

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 359, Issue 4, 1999, Pages 272-279

  Pittaluga, Anna ^a   Bonfanti, Andrea ^a   Arvigo, Daniela ^a   Raiteri, Maurizio ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

AMPA receptors; Ampakine; Aniracetam; Cyclothiazide; Kynurenate test; NMDA receptors; Nootropics; Noradrenaline release

Indexed keywords

1 (1,3 BENZODIOXOL 5 YLCARBONYL)PIPERIDINE; 6 NITRO 7 SULFAMOYLBENZO[F]QUINOXALINE 2,3 DIONE; 6 NITROQUIPAZINE MALEATE; AMPA RECEPTOR ANTAGONIST; ANIRACETAM; CYCLOTHIAZIDE; DIZOCILPINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NOOTROPIC AGENT; NORADRENALIN; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BINDING SITE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENCY; DRUG RECEPTOR BINDING; HIPPOCAMPUS; MALE; NONHUMAN; NORADRENALIN RELEASE; RAT;

EID: 0032952996     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00005352     Document Type: Article

References (41)

1. Arai A, Kessler M, Xiao P, Ambros-Ingerson J, Rogers G, Lynch G (1994) A centrally active drug that modulates AMPA receptor gated currents. Brain Res 638:343-346
2. Arai A, Kessler M, Ambros-Ingerson J, Quan A, Yigiter E, Rogers G, Lynch G (1996) Effects of a centrally active benzoylpyrrolidine drug on AMPA receptor kinetics. Neuroscience 75:573-585
3. 3H]norepinephrine release from rat hippocampal slices. J Neurochem 63:231-237
4. 3H]norepinephrine release in rat hippocampal slices. Neuropharmacology 34:141-147
5. Fedele E, Raiteri M (1996) Desensitization of AMPA receptors and AMPA-NMDA receptor interaction: An in vivo cyclic GMP microdialysis study in rat cerebellum. Br J Pharmacol 117: 1133-1138
6. Fedele E, Conti A, Raiteri M (1997) The glutamate receptor/NO/cyclic GMP pathway in the hippocampus of freely moving rats: Modulation by cyclothiazide, interaction with GABA and the behavioural consequences. Neuropharmacology 36:1393-1403
7. Fink K, Göthert M, Molderings G, Schlicker E (1989) N-Methyl-D-aspartate (NMDA) receptor-mediated stimulation of noradrenaline release, but not release of other neurotransmitters, in the rat brain cortex: Receptor location, characterization and desensitization. Naunyn Schmiedebergs Arch Pharmacol 339:514-521
8. Fink K, Bönisch H, Göthert M (1990) Presynaptic NMDA receptors stimulate noradrenaline release in the cerebral cortex. Eur J Pharmacol 185:115-117
9. Gramsbergen JB, Schmidt W, Turski WA, Schwarcz R (1992) Age-related changes in kynurenic acid production in rat brain. Brain Res 588:1-5
10. 3H]MK801 binding. Eur J Pharmacol 281 :R11-R13
11. Harley C (1991) Noradrenergic and locus coeruleus modulation of the perforant path-evoked potential in rat dentate gyrus supports a role for the locus coeruleus in attentional and memorial processes. Prog Brain Res 88:307-321
12. Hennegriff M, Arai A, Kessler M, Vanderklish P, Mutneja MS, Rogers G, Neve RL, Lynch G (1997) Stable expression of recombinant AMPA receptor subunits: Binding affinities and effects of allosteric modulators. J Neurochem 68:2424-2434
13. Heyes MP, Brew BJ, Martin A, Price RW, Salazar AM, Sidtis JJ, Yergey JA, Mouradian MM, Sadler AR, Kelip J (1991) Quinolinic acid in cerebrospinal fluid and serum HIV-1 infection: Relationship to clinical and neurological status. Ann Neurol 29:202-229
14. Isaacson JS, Nicoll RA (1991) Aniracetam reduces glutamate receptor desensitization and slows the decay of fast excitatory synaptic currents in the hippocampus. Proc Natl Acad Sci USA 88: 10936-10940
15. Ito I, Tanabe S, Kohda A, Sugiyama H (1990) Allosteric potentiation of quisqualate receptors by a nootropic drug aniracetam. J Physiol (Lond) 424:533-543
16. Izquierdo I, Medina JH, Bianchin M, Walz R, Zanatta MS, Da Silva RC, Silva MBE, Ruschel AC, Paczko N (1993) Memory processing by the limbic system: Role of specific neurotransmitter systems. Behav Brain Res 58:91-98
17. Johansen TH, Chaudhary A, Verdoorn TA (1995) Interactions among GYKI-52466, cyclothiazide, and aniracetam at recombinant AMPA and kainate receptors. Mol Pharmacol 48:946-955
18. Kessler M, Terramani T, Lynch G, Baudry M (1989) A glycine site associated with N-methyl-D-aspartic acid receptors: Characteristics and identification of a new class of antagonists. J Neurochem 52:1319-1328
19. McGaugh JL (1989) Involvement of hormonal and neuromodulatory systems in the regulation of memory storage. Annu Rev Neurosci 12:255-287
20. Moroni F, Russi P, Lombardi G, Beni M, Carlà V (1988a) Presence of kynurenic acid in the mammalian brain. J Neurochem 51:177-180
21. Moroni F, Russi P, Carlà V, Lombardi G (1988b) Kynurenic acid is present in the rat brain and its content increases during development and aging process. Neurosci Lett 94:145-150
22. Partin KM, Fleck MW, Mayer ML (1996) AMPA receptor flip/flop mutants affecting deactivation, desensitization, and modulation by cyclothiazide, aniracetam, and thiocyanate. J Neurosci 16: 6634-6647
23. Patneau DK, Vyklicky L, Mayer ML (1993) Hippocampal neurons exhibit cyclothiazide-sensitive rapidly desensitizing responses to kainate. J Neurosci 13:3496-3509
24. Pittaluga A, Raiteri M (1990) Release-enhancing glycine-dependent presynaptic NMDA receptors exist on noradrenergic terminals of hippocampus. Eur J Pharmacol 191:231-234
25. Pittaluga A, Raiteri M (1992) N-Methyl-D-aspartic acid (NMDA) and non-NMDA receptors regulating hippocampal norepinephrine release. I. Location on axon terminals and pharmacological characterization. J Pharmacol Exp Ther 260:232-237
26. Pittaluga A, Pattarini R, Raiteri M (1995) Putative cognition enhancers reverse kynurenic acid antagonism at hippocampal NMDA receptors. Eur J Pharmacol 272:203-209
27. Pittaluga A, Bonfanti A, Raiteri M (1997a) Differential desensitization of ionotropic non-NMDA receptors having distinct neuronal location and function. Naunyn Schmiedebergs Arch Pharmacol 356:29-38
28. Pittaluga A, Vaccari D, Raiteri M (1997b) The "kynurenate test", a biochemical assay for putative cognition enhancers. J Pharmacol Exp Ther 283:82-90
29. Raiteri M, Angelini F, Levi G (1974) A simple apparatus for studying the release of neurotransmitters from synaptosomes. Eur J Pharmacol 25: 411-414
30. Raiteri M, Bonanno G, Marchi M, Maura G (1984) Is there a functional linkage between neurotransmitter uptake mechanisms and presynaptic receptors? J Pharmacol Exp Ther 231:671-677
31. Smith JE, Lane JD, Shea PA, McBride WJ, Aprison MH (1975) A method for concurrent measurement of picomole quantities of acetylcholine, choline, dopamine, norepinephrine, serotonin, 5-hydroxytryptophan, 5-hydroxyindoleacetic acid, tryptophan, tyrosine, glycine, aspartate, glutamate, alanine and gamma-aminobutyric acid in single tissue samples from different areas of rat central nervous system. Anal Biochem 64:149-169
32. Staubli U, Perez Y, Xu FB, Rogers G, Ingvar M, Stone-Elander S, Lynch G (1994a) Centrally active modulators of glutamate receptors facilitate the induction of long-term potentiation in vivo. Proc Natl Acad Sci USA 91:11158-11162
33. Staubli U, Rogers G, Lynch G (1994b) Facilitation of glutamate receptors enhances memory. Proc Natl Acad Sci USA 91:777-781
34. Stone TW (1993) Neuropharmacology of quinolinic and kynurenic acids. Pharmacol Rev 45:309-379
35. Tang C-M, Shi Q-Y, Katchman A, Lynch G (1991) Modulation of the time course of fast EPSCs and glutamate channel kinetics by aniracetam. Science 254:288-290
36. Turski WA, Nakamura M, Todd WP, Carpenter BK, Wetsell WO Jr, Schwarcz R (1988) Identification and quantification of kynurenic acid in human brain tissue. Brain Res 454:164-169
37. Vyklicky L, Patneau DK, Mayer ML (1991) Modulation of excitatory synaptic transmission by drugs that reduce desensitization at AMPA/kainate receptors. Neuron 7:971-984
38. Whitton PS, Maione S, Biggs CS, Fowler RJ (1994) Tonic desensitization of hippocampal α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors regulates 5-hydroxytryptamine release in vivo. Neuroscience 63:945-948
39. Xiao P, Staubli U, Kessler M, Lynch G (1991) Selective effects of aniracetam across receptor types and forms of synaptic facilitation in hippocampus. Hippocampus 1:373-380
40. Yamada KA, Tang CM (1993) Benzothiazides inhibit rapid glutamate receptor desensitization and enhance glutamatergic synaptic currents. J Neurosci 13:3904-3915
41. Zivkovic I, Thompson DM, Bertolino M, Uzunov D, Dibella M, Costa E, Guidotti A (1995) 7-Chloro-3-methyl-3-4-dihydro-2H-1,2,4 benzothiadiazine S,S-dioxide (IDRA 21): A benzothiadiazine derivative that enhances cognition by attenuating DL-α-amino-2,3-dihydro-5-methyl-3-oxo-4-isoxazolepropanoic acid (AMPA) receptor desensitization. J Pharmacol Exp Ther 272:300-309